Loading chat...
AL SB225
Bill
Status
4/11/2017
Primary Sponsor
William Beasley
Click for details
AI Summary
SB225 Summary
-
Renames State Board of Pharmacy drug inspectors to drug investigators and clarifies pharmacists are health care providers.
-
Increases maximum permit fees for new pharmacies ($100-$200), renewals ($50-$150), ownership transfers ($150-$400), and out-of-state operations ($750-$2,000).
-
Changes drug supply chain entity registration from biennial to annual; adds packagers, third-party logistics providers, private label distributors to required registrants; establishes $4,000 civil penalty for shipping legend drugs without valid permit.
-
Prohibits prescribers from reselling compound drug products administered in their offices; requires board to recognize and enforce United States Pharmacopoeia and National Formulary standards for drug handling and compounding.
-
Repeals Sections 34-23-152 through 34-23-157 relating to drug compounding; adds Section 34-23-32.2 requiring adherence to FDA Guidelines in the Drug Quality and Security Act.
Legislative Description
Pharmacy, State Board of, inspectors renamed investigators, maximum fees increased, frequency of drug supply chain registration increased, further regulation of entities within drug supply chain provided, resale of compound drug products prohibited, Sec. 34-23-32.2 added; Secs. 34-23-152 to 34-23-157, inclusive, repealed; Secs. 20-2-9, 20-2-190, 34-23-1, 34-23-3, 34-23-9, 34-23-30, 34-23-32, 34-23-32.1, 34-23-33, 34-23-70, 34-23-92, 34-23-131, 34-23-159, 34-23-160, 34-23-162 am'd
Pharmacy, Alabama State Board of
Last Action
Pending third reading on day 20 Favorable from Health
4/20/2017